ScHARR-TAG have had a new topic confirmed. It is:
Adalimumab, etanercept, infliximab, certolizumab pegol and golimumab for the treatment of rheumatoid arthritis. Review of TA130, TA186 and TA225.
Even with our considerable expertise in this area, this is going to be a massive piece of work – there are big issues around network meta-analysis, model structure, mapping and extrapolation. And five manufacturer submissions!